These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10837440)

  • 1. Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
    Fogarty CM; Bettis RB; Griffin TJ; Keyserling CH; Nemeth MA; Tack KJ
    J Antimicrob Chemother; 2000 Jun; 45(6):851-8. PubMed ID: 10837440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
    Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
    Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.
    Brook I
    Clin Ther; 2005 Aug; 27(8):1266-73. PubMed ID: 16199251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
    Drehobl M; Bianchi P; Keyserling CH; Tack KJ; Griffin TJ
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1579-83. PubMed ID: 9210689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of upper and lower respiratory tract infections: clinical trials with cefprozil.
    Aronovitz G
    Pediatr Infect Dis J; 1998 Aug; 17(8 Suppl):S83-8. PubMed ID: 9727656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin.
    Guay DR
    Clin Ther; 2002 Apr; 24(4):473-89. PubMed ID: 12017394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media.
    Block SL; Kratzer J; Nemeth MA; Tack KJ
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S147-52. PubMed ID: 11144396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.
    Wilson R; Kubin R; Ballin I; Deppermann KM; Bassaris HP; Leophonte P; Schreurs AJ; Torres A; Sommerauer B
    J Antimicrob Chemother; 1999 Oct; 44(4):501-13. PubMed ID: 10588312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group.
    Tack KJ; Hedrick JA; Rothstein E; Nemeth MA; Keyserling C; Pichichero ME
    Arch Pediatr Adolesc Med; 1997 Jan; 151(1):45-9. PubMed ID: 9006528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of cefdinir in the treatment of patients with acute bronchitis. The Cefdinir Bronchitis Study Group.
    Sperling MJ; Puopolo A; Griffin TJ; Keyserling CH; Tack KJ
    Clin Ther; 1996; 18(4):626-34. PubMed ID: 8879891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
    Chodosh S; Lakshminarayan S; Swarz H; Breisch S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
    Tack KJ; Henry DC; Gooch WM; Brink DN; Keyserling CH
    Antimicrob Agents Chemother; 1998 May; 42(5):1073-5. PubMed ID: 9593129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
    Van Herwaarden CL; Langan CE; Siemon G; Rudolph C; Keyserling CH; Nemeth MA; Tack KJ
    Int J Infect Dis; 2000; 4(1):26-33. PubMed ID: 10689211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
    Tack KJ; Littlejohn TW; Mailloux G; Wolf MM; Keyserling CH
    Clin Ther; 1998; 20(2):244-56. PubMed ID: 9589816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefdinir: an expanded-spectrum oral cephalosporin.
    Guay DR
    Ann Pharmacother; 2000 Dec; 34(12):1469-77. PubMed ID: 11144705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S; McCarty J; Farkas S; Drehobl M; Tosiello R; Shan M; Aneiro L; Kowalsky S
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.